Osimertinib Plus Platinum-based Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Post-progression on First-Line Osimertinib: ORCHARD

Clinical Lung Cancer · Elsevier

Аннотация

Publication date: November 2026 Source: Clinical Lung Cancer, Volume 27, Issue 9 Author(s): Jonathan W. Goldman, Jonathan W. Riess, Byoung Chul Cho, Sarah B. Goldberg, Xiuning Le, Zofia Piotrowska, Isamu Okamoto, Helena A. Yu, Rosario García-Campelo, Javier de Castro Carpeño, Simon Ekman, Noemi Reguart, Marthe S. Paats, Sang-We Kim, Yu Jung Kim, Makoto Nishio, Kristen A. Marrone, Knut B. Smeland, Lizza E.L. Hendriks, Hiroaki Akamatsu

Читать у издателя →

Похожие статьи